TDNA vs BBC5YTDNATDNAAvsBBBCBBCT. Rowe Price Biotech ETF · $11MVirtus Biotech Clinical Trials ETF · $32MReturns · dividends in[…]3 years · per year[…] · $21,019+28.1%[…]5 years · per year[…] · $8,686−2.8%Cost and income0.55%Expense ratio$55 · $65 on $10k · lower wins0.65%0.00%12-mo yield$0 · $172 on $10k1.72%Risk · 1 year
Overlap: TDNA, BBC, XLVToday33.6%most shared, TDNA and BBCTDNABBCXLVTDNA—33.6%5.8%BBC33.6%—0.0%XLV5.8%0.0%—End-of-day Nov 20, 2026 · share held in common · outlined: the pair in versus
TDNA vs BBC5YATDNAT. Rowe Price Biotech[…]vsBBCBVirtus Biotech Clinical Trials$8,686MeasureTDNABBCFee0.55%0.65%Cost on $10k a year$55$65Yield0.00%1.72%5 years, per year[…]−2.8%3 years, per year[…]+28.1%Worst drop · 1Y[…]−31.9%Volatility · 1Y[…]39.0%
All Three5Y3 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼10Y/yr▲▼Drop▲▼Assets▲▼1XLVState Street Health Care Select Sector SPDR ETFReadDesk0.08%1.44%−0.1%+15.9%+18.3%+13.3%+7.5%+11.3%−10.5%$46.9B2BBBCVirtus Biotech Clinical Trials ETFReadDesk0.65%1.72%−4.1%−1.1%+14.8%+28.1%−2.8%+6.6%−31.9%$32M3ATDNAT. Rowe Price Biotech ETFReadDesk0.55%0.00%−2.4%newnewnewnew—[…]$11MEnd-of-day Nov 20, 2026 · total return, dividends in · 3Y, 5Y and 10Y per year · A and B = the pair in versus
All Three5Y3 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼10Y/yr▲▼Drop▲▼Assets▲▼1XLVState Street Health Care Select Sector SPDR ETFReadDesk0.08%1.44%−0.1%+15.9%+18.3%+13.3%+7.5%+11.3%−10.5%$46.9B2BBBCVirtus Biotech Clinical Trials ETFReadDesk0.65%1.72%−4.1%−1.1%+14.8%+28.1%−2.8%+6.6%−31.9%$32M3ATDNAT. Rowe Price Biotech ETFReadDesk0.55%0.00%−2.4%newnewnewnew—[…]$11MEnd-of-day Nov 20, 2026 · total return, dividends in · 3Y, 5Y and 10Y per year · A and B = the pair in versus
SCHD vs VIGYTDSchwabSCHDSA+26.8%vsBVVIGVanguard+8.5%Jan 1Nov 20+26.8%+8.5%+26.8%Year to date+8.5%3.1%Yield1.5%$118BAssets$116B2–0SCHD winsEnd-of-day Nov 20, 2026
JEPQ vs JEPIYTDJ.P. MorganJEPQJMA−3.4%vsBJMJEPIJ.P. Morgan+1.2%Jan 1Nov 20−3.4%+1.2%−3.4%Year to date+1.2%13.7%Yield8.4%$40.4BAssets$45.1B1–1levelEnd-of-day Nov 20, 2026
SPYM vs SPYYTDSPDRSPYMSA+2.1%vsBSSPYSPDR+1.9%Jan 1Nov 20+2.1%+1.9%+2.1%Year to date+1.9%1.1%Yield1.1%$177BAssets$756B1–0SPYM winsEnd-of-day Nov 20, 2026
Overlap: TDNA, BBC, XLVToday33.6%most shared, TDNA and BBCTDNABBCXLVTDNA—33.6%5.8%BBC33.6%—0.0%XLV5.8%0.0%—End-of-day Nov 20, 2026 · share held in common · outlined: the pair in versus
Income After Fees on $10,0001Y$136most kept, XLVXLV$144 − $8 = $136BBC$172 − $65 = $107TDNA$0 − $55 = −$55KeptFeeEnd-of-day Nov 20, 2026 · yield in dollars minus the fee